Tempus Small Cell Lung Cancer Observational Study (Sculptor)

Part of paid clinical trials in Los Alamitos, California.

Sponsor
Tempus AI
Study ID
NCT05257551
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Observation — OTHER
    No intervention

Study Details

The study is a non-interventional evaluation of participants with extensive stage (ES) SCLC who will receive diagnostic and (where possible) post-progression tumor tissue profiling, alongside plasma ctDNA and CTC biomarker profiling during standard of care therapy in both first and second line treatment.

Key Dates

Start date
Jul 13, 2022
Status verified
Jun 2026
Primary completion
Mar 31, 2029
Completion
Mar 31, 2029

Study Design

Enrollment
200 participants (estimated)

Arms

  • Arm: Patients with Extensive Stage (ES) Small Cell Lung Cancer (SCLC)
    This protocol will include participants with extensive stage small cell lung cancer receiving standard of care therapy in first and second line with tissue collected from the primary lung tumor or metastatic sites.

Primary Outcome Measure

To determine if tumor tissue transcriptional subtypes can be detected [ Time Frame: Up to 4 years ]

Central Contacts

Locations (11)

FacilityCityStateZIPSite coordinators
Cancer and Blood Specialty ClinicLos AlamitosCalifornia90720-
University of ColoradoAuroraColorado80045
Emily Adam
[email protected]
303-724-9682
Tejas Patil, MD (PRINCIPAL_INVESTIGATOR)
Illinois Cancer CarePeoriaIllinois61615
Beth Heilman
[email protected]
309-243-3617
Mohammad (Fahad) Asad, MD (PRINCIPAL_INVESTIGATOR)
Johns Hopkins UniversityBaltimoreMaryland21287
Cheryl Pai
[email protected]
410-614-1926
Lonny Yarmus, MD (PRINCIPAL_INVESTIGATOR)
Englewood Health Medical CenterEnglewoodNew Jersey07631-
University of North CarolinaChapel HillNorth Carolina27599
Ashley Delgado
[email protected]
984-520-7329
Jason Akulian, MD (PRINCIPAL_INVESTIGATOR)
TriHealth Cancer InstituteCincinnatiOhio45220
Patrick Newbury
[email protected]
513 865 5249
James Maher, MD (PRINCIPAL_INVESTIGATOR)
Ohio State UniversityColumbusOhio43210
Nicole Bullock
[email protected]
614-366-6489
Asrar Alahmadi (PRINCIPAL_INVESTIGATOR)
OhioHealth Research InstituteColumbusOhio43214-
Oklahoma Cancer Specialists and Research InstitutesTulsaOklahoma74146-
Cancer Care Association of YorkYorkPennsylvania17403
Jennifer Stough
717-741-9229
Chanh Huynh, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Los Alamitos, CA

By condition
Lung cancer
By specialty
OncologyLung oncologyLung disease
By research site
Cancer and Blood Specialty Clinic· Los Alamitos, CAUniversity of Colorado· Aurora, COIllinois Cancer Care· Peoria, ILJohns Hopkins University· Baltimore, MDEnglewood Health Medical Center· Englewood, NJUniversity of North Carolina· Chapel Hill, NC

Related Studies